Avanos Medical (AVNS) Revenue (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Revenue data on file, last reported at $182.2 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 8.78% year-over-year to $182.2 million; the trailing twelve-month figure through Mar 2026 stood at $715.9 million (up 3.87% YoY), and the FY2025 full-year result was $701.2 million, up 1.95% from the prior year.
• Revenue grew to $182.2 million in Q1 2026, from $180.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $197.4 million in Q1 2022 to a low of $159.3 million in Q1 2023.
• A 5-year average of $174.5 million and a median of $172.3 million in 2022 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 407.26% in 2022 and slipped 19.3% in 2023, its largest moves.
• Tracing AVNS's Revenue over 5 years: stood at $181.6 million in 2022, then retreated by 4.57% to $173.3 million in 2023, then rose by 3.64% to $179.6 million in 2024, then gained by 0.72% to $180.9 million in 2025, then grew by 0.72% to $182.2 million in 2026.
• Business Quant data shows AVNS's Revenue at $182.2 million in Q1 2026, $180.9 million in Q4 2025, and $177.8 million in Q3 2025.